Penn Medicine Abramson Cancer Center


 

Penn Medicine Lymphoma Panel Discussion: Toxicity Profile with IO, Salvage Regimen for cHL, Maintenance Rituximab, BTKi for MCL, and 3L Therapy for FL

21 views
May 4, 2022
0 Comments
Login to view comments. Click here to Login
2022 Updates in Care of the Hematologic Malignancies Patient